• ASBMR Embargo Policy

     
     
     
    Type Size
     

    Abstracts submitted to the ASBMR 30th Annual Meeting are embargoed — that is, unavailable for public release in written, oral and electronic communications until one hour after the abstract has been presented.

    The ASBMR is sensitive to issues of commercial confidentiality and relevant aspects of the U.S. Securities and Exchange Commission (SEC) regulations. Therefore, the ASBMR reminds all readers that all must adhere to the U.S. Securities and Exchange Commission regulations and treat all scientific information as confidential until the embargo has been lifted – one hour after the abstract has been presented. Any reader of, or listener to, ASBMR Annual Meeting content may be viewed as an “insider” by the SEC due to knowledge of information included in abstracts, particularly clinical trial abstracts. SEC regulations may call for criminal penalties for using such information.